Back to Agenda
Session 5 Users’ Experiences and Perspectives Regarding Biosimilars and Considerations on National Policy Developments
Session Chair(s)
Sabine Atzor, MPharm, RPh
Head of EU Regulatory Policies, F. Hoffmann-La Roche Ltd, Switzerland
Suzette Kox, MPharm
Senior Director International-Biosimilars Medicines Group, Medicines for Europe, Belgium
The session will continue by giving floor to health care professionals and patients and their points of view on the policy developments.
Speaker(s)
Carl-Erik Flodmark
Chief medical officer at Childhood , Childhood Obesity Unit Region Skane, Sweden
Biosimilars in Clinical Practice: the Perspective of the Hospital Pharmacist
Thijs Giezen, PharmD, PhD, MSc
, Medicines Evaluation Board, Netherlands
Patients' perspectives
Marco Greco, PhD
President , European Patients' Forum, Belgium
Payer's perspective
Margaret Dolan
Regional Pharmacy Procurement Specialist, NHS Commercial Solutions, United Kingdom
Have an account?